featured
Combining Mohs Micrographic Surgery With MART-1 Immunostaining Reduces Recurrence Rates of Melanomas
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Low Recurrence Rates for In Situ and Invasive Melanomas Using Mohs Micrographic Surgery With Melanoma Antigen Recognized by T Cells 1 (MART-1) Immunostaining: Tissue Processing Methodology to Optimize Pathologic Staging and Margin Assessment
J Am Acad Dermatol 2015 Mar 14;[EPub Ahead of Print], JR Etzkorn, JF Sobanko, R Elenitsas, JG Newman, H Goldbach, TM Shin, CJ MillerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.